Tag: SynCardia
-
Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies
— Independent dual motor ventricular design demonstrates stable full circulatory support across all study procedures — — Advancing second-generation Emperor TAH development toward a fully implantable system — TUCSON, Ariz., June 02, 2026 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (the “Company” or “Picard Medical”), parent company of SynCardia Systems LLC, maker of…
-
From Proven to Pioneering: SynCardia’s Next Leap in Artificial Heart Technology
Phoenix, AZ (November 12, 2025) – Tucson-based SynCardia Systems, LLC, the manufacturer of the SynCardia Total Artificial Heart, is a wholly owned subsidiary of Picard Medical, Inc. Picard Medical became a publicly traded company on August 29, 2025, and completed its Initial Public Offering (IPO) on September 2, 2025, raising approximately $19.5 million in gross…
